SCHEMBL3161986

SCHEMBL3161986

[CH2]CCCC(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3166953 0.91
SCHEMBL20378020 0.88 ALDH1A1 (0.47)
SCHEMBL2307386 0.81
SCHEMBL125055 0.80
SCHEMBL2818804 0.79 ALDH1A1 (0.69)
SCHEMBL1269985 0.79 ALDH1A1 (0.69)
SCHEMBL357415 0.77 ALDH1A1 (0.33)
SCHEMBL2945318 0.76 ALDH1A1 (0.64)
SCHEMBL2943010 0.76 ALDH1A1 (0.64)
SCHEMBL3040312 0.76 ALDH1A1 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3478284-B1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER UNIV CALIFORNIA (US) 2023-10-04 EP claimed
CN-116496256-A Carbonyl bridged heterocyclic compound, and composition and application thereof 北京赛特明强医药科技有限公司 2023-07-28 CN claimed
WO-2023131116-A1 CARBONYL BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2023-07-13 WO claimed
US-20230150942-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-18 US claimed
US-11560356-B2 Compounds and compositions for the treatment of cancer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-01-24 US claimed
CN-109661229-B Compounds and compositions for the treatment of cancer 加利福尼亚大学董事会 2022-06-28 CN claimed
US-20210009523-A1 Compounds and Compositions for the Treatment of Cancer RASCAL THERAPEUTICS, INC. 2021-01-14 US claimed
EP-3478284-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER The Regents of The University of California (US) 2019-05-08 EP claimed
WO-2018005678-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-01-04 WO claimed
EP-0797448-B1 COMBINATION PREPARATION, CONTAINING CYCLOSPORIN A OR FK506 OR RAPAMYCIN AND A XANTHINE DERIVATIVE HOECHST AG (DE) 2003-02-26 EP claimed
US-5824811-A 22-Thiavitamin D3 derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1998-10-20 US claimed
EP-0797448-A2 COMBINATION PREPARATION, CONTAINING CYCLOSPORIN A OR FK506 OR RAPAMYCIN AND A XANTHINE DERIVATIVE HOECHST AKTIENGESELLSCHAFT (DE) 1997-10-01 EP claimed
EP-0413278-B1 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN (JP) 1996-11-06 EP claimed
WO-1996005854-A2 COMBINATION PREPARATION, CONTAINING CYCLOSPORIN A OR FK506 OR RAPAMYCIN AND A XANTHINE DERIVATIVE HOECHST AKTIENGESELLSCHAFT (DE) 1996-02-29 WO claimed
US-5109003-A METHOD FOR THE TREATMENT OF PEPTIC ULCER DISEASE HOECHST JAPAN LIMITED (JP) 1992-04-28 US claimed
EP-0413278-A2 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN LIMITED (JP) 1991-02-20 EP claimed
US-4956374-A BACTERICIDES, CANDIDA BRISTOL-MYERS COMPANY (US) 1990-09-11 US claimed
EP-0375757-A1 COMPOUNDS EFFECTIVE IN INDUCING CELL DIFFERENTIATION WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1990-07-04 EP claimed
US-4927815-A HOMOLOGS OF 1,25-DIHYDROXYVITAMIN D3 AS AGENTS FOR THE TREATMENT OF NEOPLASTIC DISEASES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1990-05-22 US claimed
WO-1989010353-A1 COMPOUNDS EFFECTIVE IN INDUCING CELL DIFFERENTIATION WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1989-11-02 WO claimed